2-chloro-N(6)-(3-iodobenzyl)-9-(5-(methylcarbamoyl)-beta-D-ribofuranosyl)adenine,
2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide,
2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide,
2-Cl-IB-MECA,
C-IBzA-MU,
CF102 compound,
2-Cl-IB-Meca,
163042-96-4,
Cl-IB-MECA,
Namodenoson,
C-Ibza-MU,
CF-102,
CI-IB-MECA,
(2S,3S,4R,5R)-5-(2-Chloro-6-((3-iodobenzyl)amino)-9H-purin-9-yl)-3,4-dihydroxy-N-methyltetrahydrofuran-2-carboxamide,
UNII-Z07JR07J6C,
2Cl-IB-MECA,
1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE,
CHEMBL431733,
Z07JR07J6C,
CF102,
2-Chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide,
(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide,
1-(2-Chloro-6-(((3-iodophenyl)methyl)amino)-9H-purin-9-yl)-1-deoxy-N-methyl-beta-D-Ribofuranuronamide,
AK-60479,
beta-D-Ribofuranuronamide, 1-(2-chloro-6-(((3-iodophenyl)methyl)amino)-9H-purin-9-yl)-1-deoxy-N-methyl-,
beta-D-Ribofuranuronamide, 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-,
CF 102,
Namodenoson [USAN],
2-Chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide,
Namodenoson (USAN/INN),
C1-IB-MECA,
AC1MI03J,
2-Chloro-N(6)-(3-iodobenzyl)-9-(5-(methylcarbamoyl)-beta-D-ribofuranosyl)adenine,
GTPL457,
MLS002153535,
SCHEMBL1170028,
BDBM21221,
2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide,
DTXSID80167504,
HMS2235L10,
HMS3676I05,
CF-102(2-Cl-IB-MECA),
ZINC3995845,
MFCD01861178,
AKOS022181265,
AM84557,
CS-5932,
DB12885,
SB16983,
NCGC00025001-02,
AC-27390,
AN-17022,
DS-16397,
HY-12365,
SMR001230862,
AB0047892,
Chloro-IB-MECA, solid, >=98% (HPLC),
B6597,
ST24034136,
D11128,
J-009992,
2-chloro-N6-(3-iodobenzyl)adenosine-5-N-methylcarboxamide,
2-Chloro-N6-(3-iodobenzyl)-adenosine-5 inverted exclamation marka-N-methyluronamide,
(2S,3S,4R,5R)-5-(2-chloro-6-(3-iodobenzylamino)-9H-purin-9-yl)-3,4-dihydroxy-N-methyltetrahydrofuran-2-carboxamide,
(2S,3S,4R,5R)-5-(2-chloro-6-{[(3-iodophenyl)methyl]amino}-9H-purin-9-yl)-3,4-dihydroxy-N-methyloxolane-2-carboxamide,
(2S,3S,4R,5R)-5-(6-(3-iodobenzylamino)-2-chloro-9H-purin-9-yl)-3,4-dihydroxy-N-methyl-tetrahydrofuran-2-carboxamide,
(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyl-tetrahydrofuran-2-carboxamide,
1-[2-Chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-?-D-ribofuranuronamide,
Chloro-IB-MECA,
CF102 compound,
D0U0KR,
C18H18ClIN6O4,
4-BROMOPYRIDINE-2-METHANOL,
C18-H18-Cl-I-N6-O4,
NSC695672,
CID3035850,
C090034,
C107562,
2-chloro-N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine,
2-chloro-N(6)--(3-iodobenzyl)adenosine-5'-N-methyluronamide,